Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
14.25
-0.13 (-0.90%)
Mar 3, 2026, 4:00 PM EST - Market closed
Dr. Reddy's Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 18,657 | 14,654 | 7,107 | 5,779 | 14,852 | 14,829 |
Short-Term Investments | 63,932 | 43,254 | 74,363 | 96,018 | - | 19,641 |
Cash & Short-Term Investments | 82,589 | 57,908 | 81,470 | 101,797 | 14,852 | 34,470 |
Cash Growth | 37.83% | -28.92% | -19.97% | 585.41% | -56.91% | 33.92% |
Accounts Receivable | 103,206 | 90,428 | 80,298 | 48,670 | 56,764 | 45,212 |
Inventory | - | 71,065 | 57,777 | 52,833 | 50,806 | 57,218 |
Other Current Assets | 32,745 | 31,299 | 27,538 | 20,523 | 59,033 | 17,465 |
Total Current Assets | 297,549 | 250,700 | 247,083 | 224,253 | 181,855 | 148,249 |
Net Property, Plant & Equipment | 115,544 | 97,761 | 76,886 | 66,462 | 62,169 | 57,111 |
Other Intangible Assets | 102,317 | 96,803 | 36,951 | 30,881 | 27,246 | 35,948 |
Goodwill | 12,410 | 11,810 | 11,810 | 4,245 | 4,418 | 4,568 |
Long-Term Investments | 9,950 | 15,134 | 5,317 | 4,452 | 8,976 | 7,189 |
Other Long-Term Assets | 25,129 | 21,299 | 13,505 | 11,583 | 3,968 | 11,458 |
Total Assets | 562,899 | 492,989 | 387,518 | 341,876 | 292,632 | 265,491 |
Accounts Payable | 40,796 | 35,523 | 30,919 | 26,444 | 25,572 | 23,744 |
Short-Term Debt | 50,286 | 30,821 | 12,127 | 7,290 | 27,082 | 23,145 |
Current Portion of Long-Term Debt | 5,838 | 857 | 1,307 | 4,454 | 3,174 | 1,326 |
Other Current Liabilities | 61,390 | 55,622 | 51,586 | 41,655 | 38,077 | 35,498 |
Total Current Liabilities | 158,310 | 130,392 | 96,039 | 85,845 | 94,015 | 83,391 |
Long-Term Debt | 11,608 | 7,864 | 5,990 | 1,278 | 5,746 | 6,299 |
Other Long-Term Liabilities | 17,225 | 17,623 | 4,899 | 3,673 | 5,327 | 2,739 |
Total Long-Term Liabilities | 28,833 | 25,431 | 10,929 | 5,018 | 11,073 | 9,038 |
Total Liabilities | 187,143 | 155,823 | 106,968 | 90,863 | 105,088 | 92,429 |
Common Stock | 835 | 834 | 834 | -436 | 832 | 832 |
Treasury Stock | -1,904 | -2,264 | -2,261 | - | -1,601 | -1,967 |
Additional Paid-in Capital | 11,331 | 11,133 | 10,765 | - | 9,280 | 9,201 |
Accumulated Other Comprehensive Income | 6,536 | 2,098 | 2,351 | 3,391 | 3,444 | 7,339 |
Retained Earnings | 355,568 | 318,563 | 268,676 | 218,036 | 177,929 | 157,657 |
Total Common Shareholders' Equity | 372,366 | 330,364 | 280,365 | 220,991 | 189,884 | 173,062 |
Minority Interest | 3,390 | 3,999 | - | - | - | - |
Shareholders' Equity | 375,756 | 337,166 | 280,550 | 250,991 | 187,584 | 173,062 |
Total Liabilities & Equity | 562,899 | 492,989 | 387,518 | 341,876 | 292,672 | 265,491 |
Total Debt | 67,732 | 39,542 | 19,424 | 13,022 | 36,002 | 30,770 |
Net Cash (Debt) | 14,857 | 18,366 | 62,046 | 88,775 | -21,150 | 3,700 |
Net Cash Growth | -19.11% | -70.40% | -30.11% | - | - | -14.31% |
Net Cash Per Share | - | - | 74.44 | 106.71 | -25.43 | 4.45 |
Book Value | 372,366 | 330,364 | 280,365 | 220,991 | 189,884 | 173,062 |
Book Value Per Share | - | - | 336.36 | 265.63 | 228.31 | 208.11 |
Tangible Book Value | 257,639 | 221,751 | 231,604 | 185,865 | 158,220 | 132,546 |
Tangible Book Value Per Share | - | - | 277.86 | 223.41 | 190.24 | 159.39 |
Updated Jan 21, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.